SYRS - Syros Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

SYRS is currently covered by 6 analysts with an average price target of $40.54. This is a potential upside of $34.7 (594.18%) from yesterday's end of day stock price of $5.84.

Syros Pharmaceuticals's activity chart (see below) currently has 34 price targets and 46 ratings on display. The stock rating distribution of SYRS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.08% with an average time for these price targets to be met of 267.13 days.

Highest price target for SYRS is $15, Lowest price target is $7, average price target is $40.54.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 03-Oct-2023. First documented stock forecast 18-Jul-2016.

Currently out of the existing stock ratings of SYRS, 19 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$1.16 (19.86%)

11

5 months 25 days ago

2/10 (20%)

$4.2 (150.00%)

82

Buy

15

$9.16 (156.85%)

15

7 months 19 days ago

2/6 (33.33%)

$11.27 (302.14%)

30

Buy

15

$9.16 (156.85%)

16

10 months 17 days ago

1/4 (25%)

$11.68 (351.81%)

1063

Buy

13

$5.4 (71.05%)

15

1 years 25 days ago

1/4 (25%)

$9.07 (230.79%)

155

Buy

19

$14.86 (358.94%)

23

1 years 9 months 20 days ago

1/3 (33.33%)

$2.24 (59.78%)

17

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SYRS (Syros Pharmaceuticals) average time for price targets to be met?

On average it took 267.13 days on average for the stock forecasts to be realized with a an average price target met ratio 42.08

Which analyst has the current highest performing score on SYRS (Syros Pharmaceuticals) with a proven track record?

ZEGBEH JALLAH

Which analyst has the current lower performing score on SYRS (Syros Pharmaceuticals) with a proven track record?

MATT CROSS

Which analyst has the most public recommendations on SYRS (Syros Pharmaceuticals)?

Zegbeh Jallah works at CAPITAL ONE and has 21 price targets and 15 ratings on SYRS

Which analyst is the currently most bullish on SYRS (Syros Pharmaceuticals)?

Leah Rush Cann with highest potential upside - $14.86

Which analyst is the currently most reserved on SYRS (Syros Pharmaceuticals)?

Zegbeh Jallah with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?